Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 15, keine Gesamtzahl für „substrate“
Suchtreffer
Begriffe & Kennungen
Fycompa · 4.5 · Effect of perampanel on CYP3A substrates
Eintrag öffnenGalvus · 4.5 · Digoxin (Pgp substrate), warfarin (CYP2C9 substrate)
Eintrag öffnenGazyvaro · 4.5 · Obinutuzumab is not a substrate, inhibitor, or inducer of cytochrome P450 (CYP450), uridine diphosphate glucur
Eintrag öffnenGenvoya · 4.3 · Co-administration with dabigatran etexilate, a P-glycoprotein (P-gp) substrate (see section 4.5).
Eintrag öffnenGenvoya · 4.5 · Cobicistat is a strong mechanism-based inhibitor of CYP3A and is also a CYP3A substrate. Cobicistat is also a
Eintrag öffnenGilenya · 4.5 · Fingolimod is unlikely to interact with substances mainly cleared by the CYP450 enzymes or by substrates of th
Eintrag öffnenGiotrif · 4.5 · Effects of afatinib on P-gp substrates Based on in vitro data, afatinib is a moderate inhibitor of P-gp. Howev
Eintrag öffnenGiotrif · 4.5 · Interactions with BCRP In vitro studies indicated that afatinib is a substrate and an inhibitor of the transpo
Eintrag öffnenGivlaari · 4.5 · Caution is recommended during the use of medicinal products that are substrates of CYP1A2 or CYP2D6 while on t
Eintrag öffnenGlivec · 4.5 · Imatinib increases the mean Cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, indi
Eintrag öffnenGlyxambi · 4.5 · 8 is a P-glycoprotein substrate, and inhibits P-glycoprotein mediated transport of digoxin with low potency.
Eintrag öffnenGranpidam · 4.5 · 6 range of P450 substrates. Based on these pharmacokinetic results co-administration of sildenafil with ritona
Eintrag öffnenGrepid · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenHarvoni · 4.5 · Ledipasvir and sofosbuvir are substrates of drug transporter P-gp and BCRP while GS-331007 is not.
Eintrag öffnenHarvoni · 4.5 · Ledipasvir and sofosbuvir are substrates of drug transporter P-gp and BCRP while GS-331007 is not.
Eintrag öffnenHepcludex · 4.5 · 4 As a precautionary measure, close clinical monitoring is warranted when NTCP substrates (e.g. estrone-3-sulf
Eintrag öffnenHycamtin · 4.5 · Topotecan is a substrate for both ABCB1 (P-glycoprotein) and ABCG2 (BCRP). Inhibitors of ABCB1 and ABCG2 admin
Eintrag öffnenIbrance · 4.5 · 8 transporter OCT1 and then may increase the exposure of medical product substrates of this transporter (e.g.,
Eintrag öffnenIbrance · 4.5 · Concomitant use of palbociclib with statins which are substrates of CYP3A4 and/or BCRP may increase the risk o
Eintrag öffnenIbrance · 4.5 · Concomitant use of palbociclib with statins which are substrates of CYP3A4 and/or BCRP may increase the risk o
Eintrag öffnen